Phase 2 allogeneic stem cell transplantation Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Myelodysplastic SyndromeAcute Myeloid LeukaemiaRecipients of Allogeneic Stem Cell Transplantation+1 more
Vastra Gotaland Region100 enrolled5 locationsNCT06793410
Recruiting
Phase 2
Feasibility of prebiotic fibre supplementation during allogeneic stem cell transplantation
allogeneic stem cell transplantation
Metro North Hospital and Health Service36 enrolled1 locationACTRN12624000262505
Completed
Phase 2
Zometa as a prophylactic treatment for bone mineral density loss in cancer patients following allogeneic stem cell transplantation
Loss of bone mineral density in cancer patients whom have undergone allogeneic stem cell transplantation
Australasian Leukaemia and Lymphoma Group120 enrolled1 locationACTRN12607000596404